Search Page

1

A gene-based association method for mapping traits using reference transcriptome data.

Gamazon ER, Wheeler HE, Shah KP, Mozaffari SV, Aquino-Michaels K, Carroll RJ, Eyler AE, Denny JC; GTEx Consortium, Nicolae DL, Cox NJ, Im HK. Gamazon ER, et al. Nat Genet. 2015 Sep;47(9):1091-8. doi: 10.1038/ng.3367. Epub 2015 Aug 10. Nat Genet. 2015. PMID: 26258848 Free PMC article.

Cite

Share

2

Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.

Diouf B, Crews KR, Lew G, Pei D, Cheng C, Bao J, Zheng JJ, Yang W, Fan Y, Wheeler HE, Wing C, Delaney SM, Komatsu M, Paugh SW, McCorkle JR, Lu X, Winick NJ, Carroll WL, Loh ML, Hunger SP, Devidas M, Pui CH, Dolan ME, Relling MV, Evans WE. Diouf B, et al. JAMA. 2015 Feb 24;313(8):815-23. doi: 10.1001/jama.2015.0894. JAMA. 2015. PMID: 25710658 Free PMC article.

Cite

Share

3

The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.

Rudin S, Marable M, Huang RS. Rudin S, et al. Genomics Proteomics Bioinformatics. 2017 Apr;15(2):82-93. doi: 10.1016/j.gpb.2016.11.003. Epub 2017 Apr 6. Genomics Proteomics Bioinformatics. 2017. PMID: 28391009 Free PMC article. Review.

Cite

Share

4

Application of stem cell derived neuronal cells to evaluate neurotoxic chemotherapy.

Wing C, Komatsu M, Delaney SM, Krause M, Wheeler HE, Dolan ME. Wing C, et al. Stem Cell Res. 2017 Jul;22:79-88. doi: 10.1016/j.scr.2017.06.006. Epub 2017 Jun 15. Stem Cell Res. 2017. PMID: 28645005 Free PMC article.

Cite

Share

5

Pharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid Leukemia.

Nath A, Wang J, Stephanie Huang R. Nath A, et al. Mol Diagn Ther. 2017 Dec;21(6):621-631. doi: 10.1007/s40291-017-0292-x. Mol Diagn Ther. 2017. PMID: 28698977 Free PMC article. Review.

Cite

Share

6

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.

Gammal RS, Court MH, Haidar CE, Iwuchukwu OF, Gaur AH, Alvarellos M, Guillemette C, Lennox JL, Whirl-Carrillo M, Brummel SS, Ratain MJ, Klein TE, Schackman BR, Caudle KE, Haas DW; Clinical Pharmacogenetics Implementation Consortium. Gammal RS, et al. Version 2. Clin Pharmacol Ther. 2016 Apr;99(4):363-9. doi: 10.1002/cpt.269. Epub 2015 Nov 9. Clin Pharmacol Ther. 2016. PMID: 26417955 Free PMC article. Review.

Cite

Share

7

ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia.

Li M, Seiser EL, Baldwin RM, Ramirez J, Ratain MJ, Innocenti F, Kroetz DL. Li M, et al. Pharmacogenomics J. 2018 Jan;18(1):35-42. doi: 10.1038/tpj.2016.75. Epub 2016 Nov 15. Pharmacogenomics J. 2018. PMID: 27845419 Free PMC article.

Cite

Share

8

Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer.

Rose MC, Kostyanovskaya E, Huang RS. Rose MC, et al. Genomics Proteomics Bioinformatics. 2014 Oct;12(5):198-209. doi: 10.1016/j.gpb.2014.10.003. Epub 2014 Oct 28. Genomics Proteomics Bioinformatics. 2014. PMID: 25449594 Free PMC article. Review.

Cite

Share

9

Pharmacogenomics of Medications Commonly Used in the Intensive Care Unit.

Zhou S, Skaar DJ, Jacobson PA, Huang RS. Zhou S, et al. Front Pharmacol. 2018 Dec 4;9:1436. doi: 10.3389/fphar.2018.01436. eCollection 2018. Front Pharmacol. 2018. PMID: 30564130 Free PMC article. Review.

Cite

Share

10

Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyond.

Delaney C, Frank S, Huang RS. Delaney C, et al. Chin J Cancer. 2015 Apr 8;34(4):149-60. doi: 10.1186/s40880-015-0007-9. Chin J Cancer. 2015. PMID: 25962919 Free PMC article. Review.

Cite

Share